Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123199) titled 'A self-controlled, multicenter, phase III clinical trial comparing the detection rate of non-muscle invasive bladder cancer (NMIBC) between 5-aminolevulinic acid hydrochloride granules combined with endoscopic PDD fluorescence imaging and conventional endoscopic white light imaging' on April 22.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Shanghai General Hospital
Condition:
Bladder cancer
Intervention:
Gold Standard:Pathological Diagnosis Results
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-03-11
Target Sample Size: Target co...